These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26222941)

  • 1. Dysarthria and Quality of Life in neurologically healthy elderly and patients with Parkinson's disease.
    Lirani-Silva C; Mourão LF; Gobbi LT
    Codas; 2015; 27(3):248-54. PubMed ID: 26222941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Speech and voice disorders in Parkinson's disease].
    Martnez-Sánchez F
    Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acoustic analysis of prosody in females with Parkinson's disease: comparison with normal controls].
    Azevedo LL; Cardoso F; Reis C
    Arq Neuropsiquiatr; 2003 Dec; 61(4):999-1003. PubMed ID: 14762606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rate reduction and increased loudness on acoustic measures of anticipatory coarticulation in multiple sclerosis and Parkinson's disease.
    Tjaden K; Wilding GE
    J Speech Lang Hear Res; 2005 Apr; 48(2):261-77. PubMed ID: 15989391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysarthria in individuals with Parkinson's disease: a protocol for a binational, cross-sectional, case-controlled study in French and European Portuguese (FraLusoPark).
    Pinto S; Cardoso R; Sadat J; Guimarães I; Mercier C; Santos H; Atkinson-Clement C; Carvalho J; Welby P; Oliveira P; D'Imperio M; Frota S; Letanneux A; Vigario M; Cruz M; Martins IP; Viallet F; Ferreira JJ
    BMJ Open; 2016 Nov; 6(11):e012885. PubMed ID: 27856480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of voice and speech symptoms in early Parkinson's disease by the Robertson dysarthria profile.
    Defazio G; Guerrieri M; Liuzzi D; Gigante AF; di Nicola V
    Neurol Sci; 2016 Mar; 37(3):443-9. PubMed ID: 26615536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voice Use in Daily Life Studied With a Portable Voice Accumulator in Individuals With Parkinson's Disease and Matched Healthy Controls.
    Gustafsson JK; Södersten M; Ternström S; Schalling E
    J Speech Lang Hear Res; 2019 Dec; 62(12):4324-4334. PubMed ID: 31830844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acoustic investigation of stress patterns in Parkinson's disease.
    Tykalova T; Rusz J; Cmejla R; Ruzickova H; Ruzicka E
    J Voice; 2014 Jan; 28(1):129.e1-129.e8. PubMed ID: 24094802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Articulatory-acoustic vowel space: application to clear speech in individuals with Parkinson's disease.
    Whitfield JA; Goberman AM
    J Commun Disord; 2014; 51():19-28. PubMed ID: 25074511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson's disease.
    Hartelius L; Svantesson P; Hedlund A; Holmberg B; Revesz D; Thorlin T
    Folia Phoniatr Logop; 2010; 62(3):104-9. PubMed ID: 20424465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task.
    Rusz J; Cmejla R; Tykalova T; Ruzickova H; Klempir J; Majerova V; Picmausova J; Roth J; Ruzicka E
    J Acoust Soc Am; 2013 Sep; 134(3):2171-81. PubMed ID: 23967947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease.
    Rusz J; Cmejla R; Ruzickova H; Ruzicka E
    J Acoust Soc Am; 2011 Jan; 129(1):350-67. PubMed ID: 21303016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Task-based profile of vocal intensity decline in Parkinson's disease.
    Rosen KM; Kent RD; Duffy JR
    Folia Phoniatr Logop; 2005; 57(1):28-37. PubMed ID: 15655339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reception of Communicative Functions of Prosody in Hypokinetic Dysarthria due to Parkinson's Disease.
    Martens H; Van Nuffelen G; Wouters K; De Bodt M
    J Parkinsons Dis; 2016; 6(1):219-29. PubMed ID: 26889630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
    Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
    J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Analysis of Voice in Parkinson Disease Compared to Motor Performance: A Pilot Study.
    Silbergleit AK; LeWitt PA; Peterson EL; Gardner GM
    J Parkinsons Dis; 2015; 5(3):517-24. PubMed ID: 26406131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intonation and speech rate in Parkinson's disease: general and dynamic aspects and responsiveness to levodopa admission.
    Skodda S; Grönheit W; Schlegel U
    J Voice; 2011 Jul; 25(4):e199-205. PubMed ID: 21051196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing intonation deficit in motor speech disorders: an autosegmental-metrical analysis of spontaneous speech in hypokinetic dysarthria, ataxic dysarthria, and foreign accent syndrome.
    Lowit A; Kuschmann A
    J Speech Lang Hear Res; 2012 Oct; 55(5):1472-84. PubMed ID: 23033442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.